|
ADAR expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.182200E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
7.706400E-01 |
| Normal-vs-Stage2 |
7.271800E-01 |
| Normal-vs-Stage3 |
8.568000E-01 |
| Normal-vs-Stage4 |
8.479000E-01 |
| Stage1-vs-Stage2 |
8.572800E-01 |
| Stage1-vs-Stage3 |
9.350000E-01 |
| Stage1-vs-Stage4 |
6.536800E-01 |
| Stage2-vs-Stage3 |
8.309400E-01 |
| Stage2-vs-Stage4 |
6.355600E-01 |
| Stage3-vs-Stage4 |
7.301000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.429800E-01 |
| Normal-vs-AfricanAmerican |
7.454300E-02 |
| Normal-vs-Asian |
8.436400E-01 |
| Caucasian-vs-AfricanAmerican |
8.664000E-02 |
| Caucasian-vs-Asian |
7.883200E-01 |
| AfricanAmerican-vs-Asian |
8.790100E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.229200E-01 |
| Normal-vs-Female |
9.772800E-01 |
| Male-vs-Female |
4.142000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.914400E-01 |
| Normal-vs-Age(41-60Yrs) |
7.192600E-01 |
| Normal-vs-Age(61-80Yrs) |
7.554000E-01 |
| Normal-vs-Age(81-100Yrs) |
5.194200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.580000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.313400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.572400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.966000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.031600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.596800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.890000E-01 |
| Classical-VS-Follicular |
2.16619999715562E-09 |
| Classical-VS-Other |
2.319800E-02 |
| Classical-VS-Normal |
1.702420E-01 |
| Tall-VS-Follicular |
5.138200E-03 |
| Tall-VS-Other |
7.090000E-02 |
| Tall-VS-Normal |
9.454200E-01 |
| Follicular-VS-Other |
7.523800E-01 |
| Follicular-VS-Normal |
7.755300E-04 |
| Other-VS-Normal |
4.116000E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.971400E-01 |
| Normal-vs-N1 |
2.358800E-01 |
| N0-vs-N1 |
5.195200E-01 |
|
|
